FUBO vs CLOV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

FUBO

49.5
AI Score
VS
FUBO Wins

CLOV

41.5
AI Score

Investment Advisor Scores

FUBO

50score
Recommendation
HOLD

CLOV

42score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric FUBO CLOV Winner
Revenue 4.60B 1.49B FUBO
Net Income -16.30M 55.34M CLOV
Net Margin -0.4% 3.7% CLOV
Operating Income -56.02M 55.34M CLOV
ROE -2.0% 14.7% CLOV
ROA -0.4% 7.7% CLOV
Total Assets 3.94B 720.33M FUBO
Current Ratio 1.00 1.50 CLOV
Free Cash Flow -418.16M 131.55M CLOV

Relative Price Performance (Last 90 Days)

FUBO 1M: -15.7% · 3M: -12.9% CLOV 1M: -1.6% · 3M: -19.6%

Current Technical Phase

FUBO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 35

RSI (14): 35.5 · Price: $8.88

CLOV

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.5%), weak momentum, RSI 41

RSI (14): 41.5 · Price: $4.23

Fundamentals Snapshot

Metric FUBO CLOV
Market Cap — —
Forward P/E 16.1 28.2
Trailing P/E 2.3 —
Revenue (TTM) — —
Revenue Growth 0.4% 0.6%
Gross Margin 0.1% 0.2%
Operating Margin 0.0% 0.0%
EPS 3.84 -0.05
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, FUBO is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.